openPR Logo
Press release

Global Nicotine Replacement Therapy Market | Expected to Reach USD 3.54 billion (at CAGR of 4.2%) | COVID-19 Impact Covered | Forecast Period 2021-2027

08-25-2021 11:46 AM CET | Health & Medicine

Press release from: Fortune Business Insights

Nicotine Replacement Therapy Market

Nicotine Replacement Therapy Market

The global “Nicotine Replacement Therapy Market” is expected to gain momentum by exhibiting a CAGR of 4.2% between 2020 and 2027. This is attributable to increasing incidence of chronic disease such as lung cancer, strokes, and respiratory ailments. Additionally, introduction of innovative products by major companies will favor market growth. This information is published by Fortune Business Insights, in its latest report, titled, “Nicotine Replacement Therapy (NRT) Market Size, Share &COVID-19 Impact Analysis, By Type (Gums, Patches, Lozenges, Inhalers, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.”The report further observes that the market was valued at USD 2.55 billion in 2019 and is projected to reach USD 3.54 billion by 2027.

Major Nicotine Replacement Therapy Market Key players covered in the report include:
• GlaxoSmithKline plc (U.K, Europe)
• Johnson & Johnson Inc (New Jersey, U.S)
• Perrigo Company plc (Ireland, Europe)
• Pierre Fabre SA, Laboratories (France, Europe)
• Pfizer Inc. (New York, United States)
• Cipla Limited (Mumbai, India)
• British American Tobacco Plc (U.K, Europe)
• Other Players

Get Sample Report Of Nicotine Replacement Therapy Market Report at:
https://www.fortunebusinessinsights.com/enquiry/sample/nicotine-replacement-therapy-nrt-market-103362

Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for market to figure out and study the market’s needs, market size, and competition.

Nicotine Replacement Therapy Market Analysis 2021:

Draving Factors :
Increasing Incidence of Chronic Disease to Bolster Growth
According to the Center for Disease Control and Prevention (CDC), smoking cigarettes leads to over 80% to 90% of lung cancer deaths every year in the United States. Tobacco smoke consists of over 7000 chemicals, with over 70 chemicals known to cause cancer in humans. Furthermore, the increasing incidence of chronic ailments is propelling the major companies to introduce innovative nicotine replacement therapy products that aid in to curb the urge to smoke in the people. The growing tobacco addiction in the youth is further driving the demand for the NTR products that will bode well for the growth of the global nicotine replacement therapy market during the forecast period.

REGIONAL INSIGHTS
Growing Smoking Cessation Cases in North America to Propel Demand
Among all regions, North America was worth USD 1.18 billion in 2019 and is expected to hold the highest position in the global nicotine replacement therapy market share during the forecast period. This is attributable to the increasing number of people that desire to quit smoking in the US. For instance, according to the US National Institute of Health, around 70% of the total 46 million Americans smoke, desire to quit smoking. On the other hand, Europe is expected to hold the second position in the market owing to increasing government initiatives to promote anti-smoking campaigns and activities that are expected to drive the demand for nicotine replacement therapy products between 2020 and 2027.

For more information visit : https://www.fortunebusinessinsights.com/nicotine-replacement-therapy-nrt-market-103362

COMPETITIVE LANDSCAPE
Product Launches by Major Companies to Strengthen Market Position
The global nicotine replacement therapy market report observes that major companies such as GlaxoSmithKline plc and Johnson & Johnson Inc hold over 80% of the total share and are constantly focusing on consolidating their positions by introducing novel nicotine replacement therapy products in the global marketplace. Additionally, other players in the market are striving to strengthen their position by adopting strategies such as collaboration, merger and acquisition, and introduction of new products during the forecast period.

INDUSTRY DEVELOPMENT:
• June 2020: Taat Herb Co., a flagship brand of Taat Lifestyles, announced the launch of its new hemp cigarettes from the Taat stable. According to the company, the new product dramatically replicates the exact experience of smoking a traditional cigarette and contains 50mg of cannabidiol(CBD) that is effective in reducing tobacco dependency.

Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nicotine-replacement-therapy-nrt-market-103362

Table of Content:
• Introduction
o Market Scope
o Market Segmentation
o Market Methodology
o Definitions and Assumptions
• Executive Summary
• Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
• Key Insights
o Overview: Guidelines for Prescription of NRT Types
o Snapshot of Smoking Statistics
o Prevalence of Tobacco Related Cancer
o Key Industry Developments - Mergers, Acquisitions, and Partnerships
• Global Nicotine Replacement Therapy Market Analysis, Insights and Forecast, 2016-2027
o Key Findings / Summary
o Market Analysis, Insights and Forecast – By Type

Toc Continue…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Nicotine Replacement Therapy Market | Expected to Reach USD 3.54 billion (at CAGR of 4.2%) | COVID-19 Impact Covered | Forecast Period 2021-2027 here

News-ID: 2366846 • Views: 178

More Releases from Fortune Business Insights

Immunoglobulin Market to Reach USD 18,378.0 Million by 2025; FDA Approval for AD …
Market Overview: The global immunoglobulin market size is expected to reach USD 18,378.0 million by 2025 exhibiting a CAGR of 7.0% during the forecast period. The increasing diagnosis rates owing to escalating awareness regarding the treatment of immunoglobulins will have a tremendous effect on the market during the forecast period, states Fortune Business Insights in a report, titled “Immunoglobulin Market Size, Share and Industry Analysis By Route of Administration (Intravenous (IV),
Life Science Instrumentation 2021 Global Market Research report covers a detaile …
Global Life Science Instrumentation market2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Life Science Instrumentation Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. This report also studies the global Life Science Instrumentation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels
Hospital Acquired Infections Treatment 2021 Global Market Research report covers …
Global Hospital Acquired Infections Treatment market2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Hospital Acquired Infections Treatment Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. This report also studies the global Hospital Acquired Infections Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and
Anti-Inflammatory Biologics Market 2021-2026 Study & Future Prospects Including …
Anti-Inflammatory Biologics Market | 2021 Global Industry Forecast To 2026, is latest report on Global Anti-Inflammatory Biologics Industry, published by Fortune Business Insights. Report provides comprehensive information on Global Anti-Inflammatory Biologics Market and Impact of Covid-19 on Healthcare Industry. According to report Global market value of Anti-Inflammatory Biologics is to hit USD 149.80 billion value by 2027 at CAGR of 11.0%. Report segments Anti-Inflammatory Biologics Market By Drug Class (Anti-Tumor

All 5 Releases


More Releases for Nicotine

Synthetic Nicotine Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Synthetic Nicotine market analysis, which studies the Synthetic Nicotine's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Synthetic Nicotine Market 2020-2025” Research Report categorizes the global Synthetic Nicotine market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth
Nicotine Gums and Lozenges Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the Nicotine Gums and Lozenges market analysis, which studies the Nicotine Gums and Lozenges's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global "Nicotine Gums and Lozenges Market 2020-2025" Research Report categorizes the global Nicotine Gums and Lozenges market by key players, product type, applications and regions,etc. The report also covers the latest
Global Nicotine Market Research Report
This report studies the global Nicotine market status and forecast, categorizes the global Nicotine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Alchem International Siegfried CAMBREX CHARLES CITY FERTIN PHARMA JOHNSON AND JOHNSON CONSUMER INC Laboratorios Haymann Mallinckrodt Pharmaceuticals PORTON FINE
Global Nicotine Polacrilex Market Research Report
This report studies the global Nicotine Polacrilex market status and forecast, categorizes the global Nicotine Polacrilex market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report BGP HEALTHCARE Cambrex Corporate Nicobrand Alchem International DIXIE CHEMICAL FERTIN PHARMA Laboratorios Haymann MALLINCKRODT NICOBRAND PORTON FINE
Global Nicotine Gum Market Study 2015-2025, by Segment (2 mg nicotine gum, 4 mg …
Global Nicotine gum is a smoking cessation product that helps smokers to slowly overcome nicotine addiction. Nicotine is released by chewing the gum and is absorbed into the blood stream through the lining of the mouth, which helps smokers to slowly reduce their craving for nicotine. It is one of nicotine replacement therapies (NRT's) and it is an over-the-counter medication. View TOC for Research Report @ https://www.researchgoal.com/reports/99SHea20181802175 The global Nicotine Gum market
Nicotine Addiction - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Nicotine Addiction - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nicotine Addiction - Pipeline Review, H2 2017, provides an overview of the Nicotine Addiction (Central Nervous System) pipeline landscape. Nicotine addiction also called tobacco dependence is an addiction to tobacco products caused by the drug nicotine.